AstraZeneca's T2D Drug BYDUREON BCise Gets Approval In US To Treat Pediatric Patients

AstraZeneca PLC (AZN) on Friday said its BYDUREON BCise has been approved by the Food and Drug Administration to treat type 2 diabetes (T2D) in pediatric patients aged more than 10 years.

The drug is indicated as an adjunct to diet and exercise for improving glycemic control in pediatric patients with T2D.

BYDUREON BCise is the first once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment option for pediatric patients with T2D in the US, the company said.

BYDUREON BCise was approved in the US in 2017 and in the EU in 2018 for the treatment of adults with T2D.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Department store chain Sears is closing down its last store located in its home state of Illinois, CNBC reported. The company, which was founded in Chicago in 1892, plans to shut the shop, located in Simon Property Group's Woodfield Mall, on November 14. Sears' parent company, Transformco, which also manages the real estate, said it plans to maximize the value of the Woodfield Mall property and Amazon said over 1 million people have applied for a job at the tech major as part of its Career Day 2021. Job seekers from more than 170 countries have participated in the virtual event. In addition, more than 2,000 Amazon recruiters offered 30,000 individual career coaching sessions with participants in a single day.
Follow RTT